NOORULT

Merit Medical Systems IncMMSI

NasdaqHealthcareSurgical & Medical Instruments & Apparatus
Price (close)
$87.30
Market cap
$5.2B
P/E
35.8x
Revenue (TTM)
$1.6B
Net income
$145.6M
Dividend yield
—
1-year total return
9.0%
Net margin
9.2%
Revenue growth
10.2%
Debt / equity
0.44x

What Merit Medical Systems Inc does.

Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. We strive to be the most customer-focused company in healthcare. Each day we are determined to make a difference by understanding our customers’ needs and innovating and delivering a diverse range of products that improve the lives of people and communities throughout the world. We believe that long-term value is created for our customers, employees, shareholders, and communities when we focus outward and are determined to deliver an exceptional customer experience.

Merit Medical Systems, Inc. was founded in 1987 by Fred P. Lampropoulos, Kent W. Stanger, Darla Gill and William Padilla. Initially, we focused our operations on injection and insert molding of plastics. Our first product was a specialized control syringe used to inject contrast solution into a patient’s arteries for a diagnostic cardiac procedure called an angiogram. Since that time, our products and product lines have expanded substantially, both through internal research and development projects and through strategic acquisitions.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$963.9M$1.1B$1.2B$1.3B$1.4B$1.5B
Net income-$9.8M$48.5M$74.5M$94.4M$120.4M$128.5M
Free cash flow$119.3M$119.3M$69.3M$110.9M$185.7M$215.7M

More on MMSI.

Figures from Merit Medical Systems Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.